Hereditary persistence of fetal hemoglobin: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 23: Line 23:


==Causes==
==Causes==
This is usually caused by [[mutation]]s in the ''β''-globin gene cluster.{{Fact|date=September 2008}} The percentage of incorrect expression might be as low as 10-15% or as high as 100% of the total hemoglobin, usually higher in homozygotes than in heterozygotes.<ref>http://www.enerca.org/PublicPages/Anaemiascovered/HereditarypersistanceoffoetalhaemoglobinHPFH/tabid/177/Default.aspx</ref>  
This is usually caused by [[mutation]]s in the ''β''-globin gene cluster. The percentage of incorrect expression might be as low as 10-15% or as high as 100% of the total hemoglobin, usually higher in homozygotes than in heterozygotes.<ref>http://www.enerca.org/PublicPages/Anaemiascovered/HereditarypersistanceoffoetalhaemoglobinHPFH/tabid/177/Default.aspx</ref>


==Epidemiology==
==Epidemiology==

Revision as of 20:20, 20 February 2009

Hereditary persistence of fetal hemoglobin
ICD-10 D56.4
ICD-9 282.7

WikiDoc Resources for Hereditary persistence of fetal hemoglobin

Articles

Most recent articles on Hereditary persistence of fetal hemoglobin

Most cited articles on Hereditary persistence of fetal hemoglobin

Review articles on Hereditary persistence of fetal hemoglobin

Articles on Hereditary persistence of fetal hemoglobin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hereditary persistence of fetal hemoglobin

Images of Hereditary persistence of fetal hemoglobin

Photos of Hereditary persistence of fetal hemoglobin

Podcasts & MP3s on Hereditary persistence of fetal hemoglobin

Videos on Hereditary persistence of fetal hemoglobin

Evidence Based Medicine

Cochrane Collaboration on Hereditary persistence of fetal hemoglobin

Bandolier on Hereditary persistence of fetal hemoglobin

TRIP on Hereditary persistence of fetal hemoglobin

Clinical Trials

Ongoing Trials on Hereditary persistence of fetal hemoglobin at Clinical Trials.gov

Trial results on Hereditary persistence of fetal hemoglobin

Clinical Trials on Hereditary persistence of fetal hemoglobin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hereditary persistence of fetal hemoglobin

NICE Guidance on Hereditary persistence of fetal hemoglobin

NHS PRODIGY Guidance

FDA on Hereditary persistence of fetal hemoglobin

CDC on Hereditary persistence of fetal hemoglobin

Books

Books on Hereditary persistence of fetal hemoglobin

News

Hereditary persistence of fetal hemoglobin in the news

Be alerted to news on Hereditary persistence of fetal hemoglobin

News trends on Hereditary persistence of fetal hemoglobin

Commentary

Blogs on Hereditary persistence of fetal hemoglobin

Definitions

Definitions of Hereditary persistence of fetal hemoglobin

Patient Resources / Community

Patient resources on Hereditary persistence of fetal hemoglobin

Discussion groups on Hereditary persistence of fetal hemoglobin

Patient Handouts on Hereditary persistence of fetal hemoglobin

Directions to Hospitals Treating Hereditary persistence of fetal hemoglobin

Risk calculators and risk factors for Hereditary persistence of fetal hemoglobin

Healthcare Provider Resources

Symptoms of Hereditary persistence of fetal hemoglobin

Causes & Risk Factors for Hereditary persistence of fetal hemoglobin

Diagnostic studies for Hereditary persistence of fetal hemoglobin

Treatment of Hereditary persistence of fetal hemoglobin

Continuing Medical Education (CME)

CME Programs on Hereditary persistence of fetal hemoglobin

International

Hereditary persistence of fetal hemoglobin en Espanol

Hereditary persistence of fetal hemoglobin en Francais

Business

Hereditary persistence of fetal hemoglobin in the Marketplace

Patents on Hereditary persistence of fetal hemoglobin

Experimental / Informatics

List of terms related to Hereditary persistence of fetal hemoglobin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hereditary persistence of fetal hemoglobin (HPFH, BrE: Hereditary persistence of foetal haemoglobin) is a benign condition in which significant fetal hemoglobin (hemoglobin F) production continues well into adulthood, disregarding the normal shutoff point after which only adult-type hemoglobin should be produced.[1]

Causes

This is usually caused by mutations in the β-globin gene cluster. The percentage of incorrect expression might be as low as 10-15% or as high as 100% of the total hemoglobin, usually higher in homozygotes than in heterozygotes.[2]

Epidemiology

HPFH may alleviate the severity of certain hemaglobinopathies and thalassemias, and is selected for in populations with a high prevalence of these conditions (which in turn are often selected for in areas where malaria is endemic). Thus, it has been found to affect black people, as well as Greeks.[3]

Presentation

The condition is usually asymptomatic, and is only noticed when screening for other hemoglobin disorders.

References

  1. http://cancerweb.ncl.ac.uk/cgi-bin/omd?hereditary+persistence+of+foetal+haemoglobin
  2. http://www.enerca.org/PublicPages/Anaemiascovered/HereditarypersistanceoffoetalhaemoglobinHPFH/tabid/177/Default.aspx
  3. Friedman S, Schwartz E (1976). "Hereditary persistence of foetal haemoglobin with beta-chain synthesis in cis position (Ggamma-beta+-HPFH) in a negro family". Nature. 259 (5539): 138–40. doi:10.1038/259138a0. PMID 1246351. Unknown parameter |month= ignored (help)




Template:WikiDoc Sources